| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |